From Corporate Philanthropy to Creating Shared Value: Big Pharma’s New Business Models in Developing Markets Cover

.blurhash-client-img { display: none !important; }

From Corporate Philanthropy to Creating Shared Value: Big Pharma’s New Business Models in Developing Markets

NIM Marketing Intelligence Review

Volume 8 (2016): Issue 1 (May 2016)

By: N. Craig Smith

Open Access

|Apr 2016

Download Article

Download the full article as a PDF file.

DOI: https://doi.org/10.1515/gfkmir-2016-0005 | Journal eISSN: 2628-166X

Journal RSS Feed

Language: English

Page range: 30 - 35

Published on: Apr 29, 2016

Published by: Nuremberg Institute for Market Decisions

In partnership with: Paradigm Publishing Services

Publication frequency: 2 issues per year

Keywords:

Corporate Social Responsibility,

Sustainability,

Emerging Markets,

Pharma Industry

Related subjects:

Business and economics,

Political economics,

Public finance and fiscal theory,

Business management,

Marketing, sales, customer relations,

Management, organization, corporate governance,

Business management, other

© 2016 N. Craig Smith, published by Nuremberg Institute for Market Decisions
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous article Volume 8 (2016): Issue 1 (May 2016)Next article